Luxturna

voretigene neparvovec-rzyl · Spark Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Luxturna, covering 2015-12-07 to 2026-02-16. Get the full timeline:

Most recent: EMA Authorised: Luxturna (voretigene neparvovec) — Novartis Europharm Limited